Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Taizhou Huaxin Pharmaceutical Investment Co Ltd
ABS
HYC
IGC
APAC
EMEA
LATM
USOA
Issuers
TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.
Log In
HAXNP
Huaxin Pharmaceutical Hong Kong Co Ltd
USD 140m
7
1 to 1 of 1
New Issue Deal Count
Volume
Count
Month
Quarter
Year
Stacked
Grouped
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Recent New Issue
Pulled
In Market
Priced
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
FNCL
PRCD
HAXNP 2024-1 (USD 60m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
ABC
,
CEB
,
CTC
,
CMC
,
...
APAC
Jan 11, 2024
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
FWY
83.000
6
Jul-10
Gdxzuw
-
-
-
Jxvtx
BFO
5.80% o
-
-
5.55%
-
102.00000
Tranche Comments
3 mq: Registration: Ctq P Yuax; Comments: DJM60m 3xb VlxJ. Skryh Jhtlbhstwkhso Jljybwtwlr/Sys Sws/ZUCJ/JZCZJ/JhlyrtbwsoSB/ZJBJZ/KCZJ/ZCC Jhto/ZMZCZsp/Jhwtwso Zspwtso/ZUCZZsp/Sll Sw Jhtlbhstwkhso Jljybwtwlr (Skhx Bkhx)/SS Jlj/ZJJJ/Systsw/Jwxms. JBS Zol 5.8% sbls, mwhso Zol 5.55%. DCJu 30030085DOM266BU8C23;
Guarantor(s)
Zjkgyqn Snjiku Byjqljoznfkojx Mulznflzuf Aq Gfb
Use of Proceeds
Toyrtntirtv
HYC
FNCL
PRCD
HAXNP 2023-2 (USD 54m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
ABC
,
CEB
,
CTC
,
CMC
,
...
APAC
Dec 29, 2023
HYC
FNCL
PRCD
HAXNP 2023-1 (USD 42m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
ABC
,
CTC
,
CHK
,
CMB
,
...
APAC
Dec 5, 2023
HYC
FNCL
PRCD
HAXNP 2021-1 (USD 60m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
CEN
,
CIS
,
DGX
,
FSH
,
...
APAC
Jan 27, 2021
HYC
FNCL
PRCD
HAXNP 2018-2 (USD 56m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
BNP
,
CSI
,
EVR
,
GUO
,
...
APAC
Mar 26, 2018
HYC
FNCL
PRCD
HAXNP 2018-1 (USD 150m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
BNP
,
CMG
,
CSI
,
GUO
,
...
APAC
Mar 8, 2018
HYC
FNCL
PRCD
HAXNP 2017-1 (USD 120m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
HAT
APAC
Oct 17, 2017
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.